Combined hepatocellular carcinoma and cholangiocarcinoma: A case report and review of the literature

Hepatobiliary and Pancreatic Diseases International

Volumn 6, Issue 6, 2007, Pages 656-659

  Zhou, Yan Ming ^a   Yang, Jia Mei ^a   Wang, Bin ^a   Xu, Feng ^a   Tong, Ying ^a   Li, Dian Qi ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Combined hepatocellular carcinoma and cholangiocarcinoma; Hepatectomy

Indexed keywords

ADULT; ARTICLE; BILE DUCT CARCINOMA; BLOOD ANALYSIS; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; ECHOGRAPHY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; METASTASIS; MICROSCOPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT INDICATION; TUMOR DIFFERENTIATION;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 37849036043     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-156.
2. Tang D, Nagano H, Nakamura M, Wada H, Marubashi S, Miyamoto A, et al. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma. J Gastrointest Surg 2006; 10:987-998.
3. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol 1949;25:647-655.
4. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer 1985; 55:124-135.
5. Yano Y, Yamamoto J, Kosuge T, Sakamoto T, Yamasaki S, Shimada K, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol 2003;33:283-287.
6. Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002; 94:2040-2046.
7. Sasaki A, Kawano K, Aramaki M, Ohno T, Tahara K, Takeuchi Y, et al. Clinicopathologic study of mixed hepatocellular and cholangiocellular carcinoma: modes of spreading and choice of surgical treatment by reference to macroscopic type. J Surg Oncol 2001;76:37-46.
8. Ng IO, Shek TW, Nicholls J, Ma LT. Combined hepatocellular-cholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol 1998;13:34-40.
9. Liu CL, Fan ST, Lo CM, Ng IO, Lam CM, Poon RT, et al. Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg 2003;138:86-90.
10. Koh KC, Lee H, Choi MS, Lee JH, Paik SW, Yoo BC, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg 2005;189:120-125.
11. Sanada Y, Shiozaki S, Aoki H, Takakura N, Yoshida K, Yamaguchi Y. A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma Assessment of enhancement patterns on dynamics computed tomography before resection. Hepatol Res 2005;32:185-195.
12. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 1996;11:758-764.